Post-transcriptional and post-translational regulation of insulin-like growth factor binding protein-3 and -4 by insulin-like growth factor-I in uterine myometrial cells

Growth Hormone and IGF Research

Volumn 10, Issue 1, 2000, Pages 20-27

  Huynh, Hung ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

IGF I; IGFBP 4; mRNA stability; Myometrium

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; DNA SYNTHESIS; DRUG EFFECT; GENE EXPRESSION; MITOGENESIS; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROCESSING; RAT; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 0034113060     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2000.0137     Document Type: Article

References (34)

1. LeRoith D., Clemmons D., Nissley P., Rechler M. M. NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med. 116:1992;854-862.
2. Resnicoff M., Abraham D., Yutanawiboonchai W. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469.
3. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:1995;249-252.
4. Clemmons D. R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytok Growth Fact Rev. 8:1997;45-62.
5. Oh Y. M., Nagalla S. R., Yamanaka Y., Kim H. S., Wilson E., Rosenfeld R. G. Synthesis and characterization of insulin-like growth factor binding protein (IGFBP)-7 -Recombinant human MAC25 protein specifically binds IGF-I and II. J Biol Chem. 271:1996;30322-30325.
6. Jones J. I., Clemmons D. R. Insulin-like growth factors and their binding proteins: biological actions. Endo Rev. 16:1995;3-34.
7. Oh Y., Muller H. L., Lamson G., Rosenfeld R. G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem. 268:1993;14964-14971.
8. Oh Y., Muller H. L., Pham H., Rosenfeld R. G. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem. 268:1993;26045-26048.
9. Oh Y., Mullers H. L., Ng L., Rosenfeld R. G. Transforming growth factor-b-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem. 270:1995;13589-13592.
10. Villaudy J., Delbe J., Blat C., Desauty G., Golde A., Harel L. An IGF binding protein is an inhibitor of FGF stimulation. J Cell Physiol. 149:1991;492-496.
11. Imbenotte J., Liu L., Desauty G., Harel L. Stimulation by TGFb of chick embryo fibroblasts inhibited by an IGFBP-3. Exp Cell Res. 199:1992;229-233.
12. Liu L., Delbe J., Blat C., Zapf J., Harel L. Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II. J Cell Physiol. 153:1993;15-21.
13. Valentinis B., Bhala A., DeAngelis T., Baserga R., Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol. 9:1995;361-367.
14. Schuller A. G. P., Pintar J. E. Embryonic growth deficit in IGFBP-4 deficient mice. 80th Annual Meeting of the Endocrine Society, 1998;59-60.
15. Huynh H., Beamer W. D., Pollak M. Over-expression of insulin-like growth factor binding protein 4 (IGFBP-4) in MCF-7 breast cancer cells is associated with reduced responsiveness to insulin-like growth factors in vitro and reduced tumour growth in vivo. Int J Oncol. 11:1997;193-197.
16. Marinaro J. A., Hendrich E. C., Leeding K. S., Bach L. A. HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6. Am J Physiol. 276:1999;E536-E542.
17. Huynh H. T., Pollak M. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine IGF binding protein 3 gene expression. Cancer Res. 54:1994;3115-3119.
18. Murphy L. J., Ghahary A. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endo Rev. 11:1990;443-453.
19. Huynh H. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor I. Int J Oncol. 12:1998;427-432.
20. Pratt S. E., Pollak M. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of IGF binding proteins in conditioned media. Cancer Res. 53:1993;5193-5198.
21. Liu X-J., Malkowski M., Guo Y., Erickson G. F., Shimasaki S., Ling N. Development of specific antibodies to rat insulin-like growth factor binding proteins (IGFBP-2 to -6): Analysis of IGFBP production by rat granulosa cells. Endocrinology. 132:1993;1176-1183.
22. Huynh H. T., Pollak M. IGF-I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res. 53:1993;5585-5588.
23. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1,-2,-3,-4,-5 and -6). Prog Growth Factor Res. 3:1991;243-266.
24. Adams M. D., Kelley J. M., Gocayne J. D. Complementary DNA sequencing: expressed sequence tags and human genome project. Science. 252:1991;1651-1656.
25. Noda M., Yoon K., Rodan G. A. Cyclic AMP-mediated stabilization of osteocalcin mRNA in rat osteoblast-like cells treated with parathyroid hormone. J Biol Chem. 263:1988;18574-18577.
26. Huynh H. T., Yang X., Pollak M. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ. 7:1996;1501-1506.
27. Kanzaki S., Hilliker S., Baylink D. J., Mohan S. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology. 134:1994;383-392.
28. Neely E. K., Rosenfeld R. G. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells. Endocrinol. 130:1992;985-993.
29. Conover C. A., Liu F., Powell D., Rosenfeld R. G., Hintz R. L. Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation. J Clin Invest. 83:1989;852-859.
30. Guyette W. A., Matusik R. J., Rosen J. M. Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell. 17:1979;1013-1023.
31. Raghow R., Postlethwaite A. E., Keski-Oja J., Moses H. L., Kang A. H. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest. 79:1987;1285-1288.
32. Hamalainen L., Oikarinen J., Kivirikko K. I. Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of cortisol. J Biol Chem. 260:1985;720-725.
33. Raghow R., Gossage D., Kang A. H. Pretranslational regulation of type I collagen, fibronectin, and a 50-kilodalton noncollagenous extracellular protein by dexamethasone in rat fibroblasts. J Biol Chem. 261:1986;4677-4684.
34. Mullner E. W., Kuhn L. C. A stem-loop in the 3¢ untranslated region mediates iron-dependent regulation of trnsferrin receptor mRNA stability in the cytoplasm. Cell. 53:1988;815-825.